RxDoctor Payments Data

Roy Bardwell, DO

Family Medicine · Tinley Park, ILNPI 1154562080

Payments from drug & device makers

$7,997in general payments, 2019–2025

Across 450 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Novo Nordisk$1K
  • Pfizer$631
  • Lilly USA, LLC$522
  • Boehringer Ingelheim$418
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$7,958100%
  • Education$390%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,997 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$91,256
Medicare patients
119
Services billed
1,693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide101$128,524
TrulicityDulaglutide38$59,404
OzempicSemaglutide44$54,183
JardianceEmpagliflozin46$44,429
FarxigaDapagliflozin Propanediol30$32,501
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$26,597
EliquisApixaban13$19,728
LinzessLinaclotide23$18,924
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen545$18,696
Bydureon BciseExenatide Microspheres12$15,556
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog15$15,152
XareltoRivaroxaban15$11,961
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl50$11,286
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$10,929
Varenicline Tartrate25$6,781

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$522$187,928139 claims
Novo NordiskOzempic$1,010$54,18344 claims
Boehringer IngelheimJardiance$418$44,42946 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,140$43,43048 claims
GSKTrelegy Ellipta, Breo Ellipta$59$31,40733 claims
PfizerEliquis$631$19,72813 claims
AbbVieLinzess$1,804$18,92423 claims
Johnson & JohnsonXarelto$286$11,96115 claims
Hikma Pharmaceuticals USABuprenorphine-Naloxone$34$11,28650 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Tinley Park

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →